EUVIMEDEUVIMED entdecken
Crossref

From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia

Ghazi Elamin, Aimen Aljoundi, Mahmoud E.S. Soliman

Innovation Discovery · 2024

DOI: 10.53964/id.2024007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovation Discovery, 2024. Verfasst von Ghazi Elamin und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia

Zitieren

APA

Elamin, G., Aljoundi, A., & Soliman, M. E. (2024). From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia. Innovation Discovery. https://doi.org/10.53964/id.2024007

Vancouver

Elamin G, Aljoundi A, Soliman ME. From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia. Innovation Discovery. 2024. doi:10.53964/id.2024007

BibTeX
@article{Elamin2024,
  author = {Elamin, Ghazi and Aljoundi, Aimen and Soliman, Mahmoud E.S.},
  title = {From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia},
  journal = {Innovation Discovery},
  year = {2024},
  doi = {10.53964/id.2024007}
}
Kostenlos starten →